Some patients who have taken Ozempic® injections, or Wegovy®, Rybelsus®, Mounjaro®, Saxenda®, Trulicity®, Zepbound® or Victoza® have experienced gastroparesis, persistent vomiting (more than 4 weeks) stomach paralyzed/not working, persistent nausea or diarrhea (more than 4 weeks), and even death.
Women who developed a brain meningioma after receiving Depo-Provera or Depo-SubQ Provera 104 injections are filing lawsuits.
Research reports link the use of dupilumab (the active ingredient in Dupixent) with cutaneous T-cell lymphoma (CTCL).
Some patients who have taken GLP-1 injections (Ozempic®, Wegovy®, Mounjaro®, Zepbound®, Rybelsus®, Saxenda®, Trulicity® or Victoza®) have experienced vision loss or blindness as a result of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION).
© 2018-2026 Trustwell Law Group LLP
